The present study suggests that the ratio of the serum LHCGR forms (sLHCGR:hCG-sLHCGR) could serve as a superior independent marker for Down’s syndrome and significantly increase the efficiency of the current prenatal screening program without compromising the false positive rate. This evidence concerns the gene LHCGR and Down syndrome.